<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Little is known about stepwise deregulation of specific genes leading to lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Aberrant myc gene expression in transgenic mice is correlated with B cell <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We generated a unique transgenic mouse model in which deregulated murine E mu-N-myc transgene expression leads to development of indolent B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> cells were monoclonal, morphologically mature and surface immunoglobulin expressing B cells </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> arose in a disease course and exhibited a cytoarchitectural appearance reminiscent of human follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Yet <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells were staged as preB since they failed to rearrange the immunoglobulin light chain genes </plain></SENT>
<SENT sid="6" pm="."><plain>Retroviral insertion mutagenesis analyses of adult transgenic mice infected as newborns with murine <z:hpo ids='HP_0001909'>leukemia</z:hpo> virus revealed decreased disease latency, increased <z:hpo ids='HP_0002665'>lymphoma</z:hpo> incidence and a histologically more mature <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type </plain></SENT>
<SENT sid="7" pm="."><plain>Proviral insertion sites were not equivalent when accelerated E mu-N-myc indolent <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were compared to accelerated c-myc preB cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The bcl-2 gene was not disrupted in either spontaneous or provirally accelerated E mu-N-myc <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> in N-myc-associated indolent B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> can proceed along diverse pathways involving distinctly different combinations of deregulated and/or intact genes than those pathways described in highly aggressive forms of myc-related murine preB cell disease </plain></SENT>
</text></document>